Repaglinide is an antidiabetic drug in the class of medications known as
meglitinides, and was invented in 1983. Repaglinide is an oral medication used
PRANDIN® (repaglinide) is an oral blood glucose-lowering drug of the
meglitinide class used in the management of type 2 diabetes mellitus (also
known as ...
Jul 15, 2016 ... Repaglinide: learn about side effects, dosage, special precautions, and more on
Dec 11, 2014 ... Information about repaglinide (Prandin), a drug prescribed for the treatment of
high blood sugar (glucose) in patient's with diabetes.
Jun 27, 2016 ... Repaglinide tablets are an oral antidiabetic medicine containing repaglinide
which helps your pancreas produce more insulin and thereby ...
Repaglinide induces an early insulin response to meals decreasing postprandial
blood glucose levels. It should only be taken with meals and meal-time doses ...
www.medicines.org.uk/EMC/medicine/24635/SPC/Repaglinide 0.5 mg Tablets/
Jul 11, 2016 ... Repaglinide is indicated in adults with type 2 diabetes mellitus whose
hyperglycaemia can no longer be controlled satisfactorily by diet, weight ...
Repaglinide lowers blood glucose by encouraging your pancreas to produce
more insulin. It works quickly so is particularly helpful in controlling blood sugar ...
(repaglinide) is an oral blood glucose-lowering drug of the meglitinide class used
in ... PRANDIN tablets contain 0.5 mg, 1 mg, or 2 mg of repaglinide. In addition ...
Apr 17, 2015 ... Repaglinide (Prandin) is used to treat people with type 2 diabetes who can't
manage their condition by diet and exercise alone.